STIM Peter Donato sells $293K worth of shares
Jan 03, 2026, 5:41 AM
0.00%
What does STIM do
Neuronetics, based in Malvern, Pennsylvania, develops the NeuroStar Advanced Therapy System, a TMS device for treating major depressive disorder. The company went public on June 28, 2018, and employs 202 people.
Peter Donato sold 18,061 shares of STIM on 7 March at $16.21 per share, worth a total of $293K. They now own 0 STIM shares, or a 100% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.